276 related articles for article (PubMed ID: 17075380)
1. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
2. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
5. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
6. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
[TBL] [Abstract][Full Text] [Related]
7. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
[TBL] [Abstract][Full Text] [Related]
9. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
[TBL] [Abstract][Full Text] [Related]
11. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
[TBL] [Abstract][Full Text] [Related]
12. Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma.
Li Y; Meng G; Guo QN
Exp Mol Pathol; 2008 Jun; 84(3):234-9. PubMed ID: 18501891
[TBL] [Abstract][Full Text] [Related]
13. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
14. New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis.
Luk F; Yu Y; Dong HT; Walsh WR; Yang JL
Cancer Genomics Proteomics; 2011; 8(2):65-75. PubMed ID: 21471516
[TBL] [Abstract][Full Text] [Related]
15. Annexin 2 expression is reduced in human osteosarcoma metastases.
Gillette JM; Chan DC; Nielsen-Preiss SM
J Cell Biochem; 2004 Jul; 92(4):820-32. PubMed ID: 15211578
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
[TBL] [Abstract][Full Text] [Related]
17. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications in osteogenic differentiation and transformation.
Thomas D; Kansara M
J Cell Biochem; 2006 Jul; 98(4):757-69. PubMed ID: 16598744
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
